3090.TW
Nichidenbo Corporation [3090.TW] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
3090.TW Stock Summary
Top 10 Correlated Stocks
3090.TW
In the News
3090.TW Financial details
Company Rating
Buy
Market Cap
12.95B
Income
706.31M
Revenue
10.66B
Book val./share
29.32
Cash/share
12.65
Dividend
5.5
Dividend %
9.72%
Employees
154
Optionable
No
Shortable
Yes
Earnings
02 May 2024
P/E
15.99
Forward P/E
-
PEG
-7.65
P/S
1.16
P/B
1.92
P/C
4.61
P/FCF
9.6
Quick Ratio
1.97
Current Ratio
2.56
Debt / Equity
0.25
LT Debt / Equity
0
-
-
EPS (TTM)
3.37
EPS next Y
-
EPS next Q
-
EPS this Y
-20.42%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
0.42%
Revenue last 5Y
3.85%
Revenue Q/Q
-7.71%
EPS Q/Q
-62.5%
-
-
-
-
SMA20
-
SMA50
5.26%
SMA100
5.26%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
12%
ROC
0.16%
Gross Margin
16%
Oper. Margin
10%
Profit Margin
7%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
51.2-64.5
52W High
-8.91%
52W Low
+14.31%
RSI
41
Rel Volume
1.71
Avg Volume
643.83K
Volume
1.1M
Perf Week
-3.95%
Perf Month
-5.36%
Perf Quarter
1.75%
Perf Half Y
0.52%
-
-
-
-
Beta
0.57
-
-
Volatility
0.86%, 0.68%
Prev Close
-1.52%
Price
58.3
Change
-1.52%
3090.TW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 49.37 | 51.73 | 61.08 | 56.22 | 51.07 | |
| Net income per share | 3.32 | 3.36 | 4.59 | 4.26 | 3.39 | |
| Operating cash flow per share | 7.21 | 2.6 | 0.15 | 5.13 | 4.21 | |
| Free cash flow per share | 7.12 | 2.52 | 0.09 | 5.09 | 4.18 | |
| Cash per share | 8.54 | 10.05 | 8.86 | 14.21 | 12.9 | |
| Book value per share | 23.45 | 23.3 | 25.05 | 35.55 | 29.88 | |
| Tangible book value per share | 24.43 | 24.97 | 27.07 | 35.44 | 29.82 | |
| Share holders equity per share | 23.45 | 23.3 | 25.05 | 35.55 | 29.88 | |
| Interest debt per share | 8.78 | 9.58 | 12.23 | 6.57 | 7.98 | |
| Market cap | 9.49B | 8.97B | 9.63B | 9.77B | 12.12B | |
| Enterprise value | 10.23B | 9.77B | 10.85B | 9.52B | 11.63B | |
| P/E ratio | 15.99 | 14.95 | 11.75 | 12.36 | 17.16 | |
| Price to sales ratio | 1.08 | 0.97 | 0.88 | 0.94 | 1.14 | |
| POCF ratio | 7.37 | 19.33 | 350.35 | 10.26 | 13.81 | |
| PFCF ratio | 7.46 | 19.95 | 615.31 | 10.33 | 13.9 | |
| P/B Ratio | 2.26 | 2.15 | 2.15 | 1.48 | 1.94 | |
| PTB ratio | 2.26 | 2.15 | 2.15 | 1.48 | 1.94 | |
| EV to sales | 1.16 | 1.06 | 0.99 | 0.91 | 1.09 | |
| Enterprise value over EBITDA | 11.76 | 10.7 | 9.09 | 8.66 | 12.88 | |
| EV to operating cash flow | 7.94 | 21.05 | 394.76 | 10 | 13.25 | |
| EV to free cash flow | 8.04 | 21.73 | 693.32 | 10.07 | 13.33 | |
| Earnings yield | 0.06 | 0.07 | 0.09 | 0.08 | 0.06 | |
| Free cash flow yield | 0.13 | 0.05 | 0 | 0.1 | 0.07 | |
| Debt to equity | 0.37 | 0.41 | 0.49 | 0.18 | 0.25 | |
| Debt to assets | 0.21 | 0.22 | 0.24 | 0.13 | 0.17 | |
| Net debt to EBITDA | 0.86 | 0.87 | 1.02 | -0.22 | -0.55 | |
| Current ratio | 2.16 | 2.06 | 1.96 | 3.11 | 2.71 | |
| Interest coverage | 28.3 | 46.68 | 79.52 | 26.51 | 11.12 | |
| Income quality | 1.57 | 0.52 | 0.02 | 0.53 | 1.24 | |
| Dividend Yield | 0.12 | 0.07 | 0.06 | 0.07 | 0.1 | |
| Payout ratio | 1.96 | 1.04 | 0.68 | 0.9 | 1.66 | |
| Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0 | 0.01 | 0.01 | |
| Capex to operating cash flow | -0.01 | -0.03 | -0.43 | -0.01 | -0.01 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.44 | -0.37 | -0.31 | -0.17 | -0.19 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 41.86 | 41.95 | 50.84 | 58.36 | 47.7 | |
| ROIC | 0.11 | 0.1 | 0.13 | 0.11 | 0.09 | |
| Return on tangible assets | 0.08 | 0.08 | 0.09 | 0.08 | 0.08 | |
| Graham Net | 8.8 | 9.05 | 8.09 | 18.66 | 14.99 | |
| Working capital | 3.2B | 3.34B | 3.69B | 5.53B | 5.09B | |
| Tangible asset value | 4.37B | 4.46B | 4.84B | 6.58B | 6.22B | |
| Net current asset value | 3.06B | 3.19B | 3.54B | 5.42B | 4.96B | |
| Invested capital | 0.37 | 0.41 | 0.49 | 0.18 | 0.25 | |
| Average receivables | 3.05B | 2.98B | 3.28B | 3.35B | 3.32B | |
| Average payables | 969.66M | 960.87M | 1.11B | 1.02B | 936.07M | |
| Average inventory | 2.11B | 1.58B | 2.03B | 2.38B | 2.13B | |
| Days sales outstanding | 119.69 | 120.82 | 117.21 | 111.62 | 117.78 | |
| Days payables outstanding | 41.89 | 51.43 | 47.28 | 37.57 | 39.58 | |
| Days of inventory on hand | 75.91 | 77.52 | 100.25 | 97.65 | 78.07 | |
| Receivables turnover | 3.05 | 3.02 | 3.11 | 3.27 | 3.1 | |
| Payables turnover | 8.71 | 7.1 | 7.72 | 9.72 | 9.22 | |
| Inventory turnover | 4.81 | 4.71 | 3.64 | 3.74 | 4.68 | |
| ROE | 0.14 | 0.14 | 0.18 | 0.12 | 0.11 | |
| Capex per share | -0.09 | -0.08 | -0.07 | -0.04 | -0.03 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 12.91 | 12.27 | 12.26 | 13.8 | 12.5 | |
| Net income per share | 0.73 | 0.72 | 0.89 | 1.28 | 0.48 | |
| Operating cash flow per share | 5.05 | 2.34 | 0.17 | -0.98 | 2.59 | |
| Free cash flow per share | 5.04 | 2.27 | 0.23 | -0.98 | 2.58 | |
| Cash per share | 14.21 | 14.61 | 15.07 | 11.12 | 12.65 | |
| Book value per share | 35.55 | 32.65 | 27.8 | 29.45 | 29.32 | |
| Tangible book value per share | 35.44 | 32.57 | 27.7 | 29.38 | 29.26 | |
| Share holders equity per share | 35.55 | 32.65 | 27.8 | 29.45 | 29.32 | |
| Interest debt per share | 6.43 | 5.71 | 6.46 | 8.33 | 7.58 | |
| Market cap | 9.77B | 12.39B | 12.23B | 12.52B | 12.36B | |
| Enterprise value | 9.52B | 11.89B | 10.82B | 12.13B | 11.86B | |
| P/E ratio | 18.08 | 20.63 | 16.43 | 11.72 | 29.99 | |
| Price to sales ratio | 4.08 | 4.84 | 4.78 | 4.35 | 4.65 | |
| POCF ratio | 10.42 | 25.39 | 344.08 | -61.28 | 22.41 | |
| PFCF ratio | 10.43 | 26.15 | 255.34 | -61.04 | 22.53 | |
| P/B Ratio | 1.48 | 1.82 | 2.11 | 2.04 | 1.98 | |
| PTB ratio | 1.48 | 1.82 | 2.11 | 2.04 | 1.98 | |
| EV to sales | 3.97 | 4.64 | 4.23 | 4.21 | 4.46 | |
| Enterprise value over EBITDA | 52.38 | 53.64 | 39.67 | 32.75 | 57.72 | |
| EV to operating cash flow | 10.16 | 24.35 | 304.48 | -59.37 | 21.51 | |
| EV to free cash flow | 10.17 | 25.08 | 225.95 | -59.14 | 21.63 | |
| Earnings yield | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | |
| Free cash flow yield | 0.1 | 0.04 | 0 | -0.02 | 0.04 | |
| Debt to equity | 0.18 | 0.17 | 0.23 | 0.28 | 0.25 | |
| Debt to assets | 0.13 | 0.12 | 0.14 | 0.18 | 0.17 | |
| Net debt to EBITDA | -1.34 | -2.29 | -5.16 | -1.05 | -2.41 | |
| Current ratio | 3.11 | 3.28 | 2.22 | 2.56 | 2.71 | |
| Interest coverage | 12.1 | 13.46 | 15.06 | 17.72 | 8.04 | |
| Income quality | 5.77 | 2.51 | 0.14 | -0.6 | 5.35 | |
| Dividend Yield | 0 | 0 | 0 | 0.09 | 0 | |
| Payout ratio | 0 | 0 | 0 | 4.38 | 0 | |
| Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Capex to operating cash flow | 0 | -0.03 | 0.35 | 0 | -0.01 | |
| Capex to revenue | 0 | -0.01 | 0 | 0 | 0 | |
| Capex to depreciation | -0.06 | -1.89 | 1.63 | -0.1 | -0.38 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 24.12 | 22.99 | 23.62 | 29.12 | 17.87 | |
| ROIC | 0.02 | 0.02 | 0.03 | 0.04 | 0.02 | |
| Return on tangible assets | 0.01 | 0.02 | 0.02 | 0.03 | 0.01 | |
| Graham Net | 18.66 | 18.3 | 13.06 | 14.12 | 14.71 | |
| Working capital | 5.53B | 5.73B | 4.66B | 5.03B | 5.09B | |
| Tangible asset value | 6.58B | 6.8B | 5.78B | 6.13B | 6.22B | |
| Net current asset value | 5.42B | 5.62B | 4.54B | 4.91B | 4.96B | |
| Invested capital | 0.18 | 0.17 | 0.23 | 0.28 | 0.25 | |
| Average receivables | 3.39B | 3.2B | 3.31B | 3.73B | 3.74B | |
| Average payables | 857.89M | 852M | 847.23M | 954.26M | 1B | |
| Average inventory | 2.33B | 2.15B | 1.96B | 1.91B | 1.91B | |
| Days sales outstanding | 119.89 | 112.84 | 120.09 | 126.63 | 116.45 | |
| Days payables outstanding | 40.07 | 33.76 | 37.01 | 38.2 | 38.52 | |
| Days of inventory on hand | 104.15 | 82.67 | 80.71 | 70.26 | 75.96 | |
| Receivables turnover | 0.75 | 0.8 | 0.75 | 0.71 | 0.77 | |
| Payables turnover | 2.25 | 2.67 | 2.43 | 2.36 | 2.34 | |
| Inventory turnover | 0.86 | 1.09 | 1.12 | 1.28 | 1.18 | |
| ROE | 0.02 | 0.02 | 0.03 | 0.04 | 0.02 | |
| Capex per share | 0 | -0.07 | 0.06 | 0 | -0.01 |
3090.TW Frequently Asked Questions
What is Nichidenbo Corporation stock symbol ?
Nichidenbo Corporation is a TW stock and trading under the symbol 3090.TW
What is Nichidenbo Corporation stock quote today ?
Nichidenbo Corporation stock price is $58.3 today.
Is Nichidenbo Corporation stock public?
Yes, Nichidenbo Corporation is a publicly traded company.
Company Profile
- Volume Average 643.83K
- Market Capitalization 12.95B
- Employee 154
- CEO Mr. Wei Lin Chou M.B.A.
- Headquarters New Taipei City,TW
- IPO Date 2007-12-31
-
Website
https://www.ndb.com.tw 
Nichidenbo Corporation supplies passive electronic components worldwide. The company offers aluminum electrolytic and solid, multilayer ceramic, electric double layer, and film capacitors; and metal oxide varistors. It also provides resistors, inductors, and switches; and power and RF inductors, power transformers, signal magnetic products, EMC coils, sensors, actuators, power and automatic modules, magnetic material products, ceramic products, and connection products, as well as components for medical equipment. Nichidenbo Corporation was founded in 1993 and is headquartered in New Taipei City, Taiwan.
